澳华内镜(688212.SH)业绩快报：2025年归母净利润1146.19万元，同比减少45.45%

Core Viewpoint - The company reported a slight increase in revenue but a significant decline in net profit, indicating challenges in maintaining profitability despite revenue growth [1] Financial Performance - The company achieved an operating revenue of 774 million yuan, representing a year-on-year growth of 3.20% [1] - The net profit attributable to the parent company was 11.46 million yuan, a decrease of 45.45% year-on-year [1] - The net profit attributable to the parent company, excluding non-recurring gains and losses, was -7.11 million yuan, showing a slight decline year-on-year [1] Asset and Equity Position - At the end of the reporting period, total assets amounted to 2.011 billion yuan, an increase of 15.03% compared to the beginning of the reporting period [1] - The equity attributable to the parent company was 1.313 billion yuan, a decrease of 3.90% from the beginning of the reporting period [1] Market and Product Development - The company made significant progress in overseas market access and business expansion, resulting in rapid growth in overseas sales [1] - The successful launch of the new flagship model AQ400 contributed to performance growth [1] Cost Structure and Profitability - The sales structure of the company's products underwent a phase change, leading to a decline in overall gross margin [1] - The company increased investments in marketing, brand influence, product iteration, and new technology research and development, resulting in high sales, management, and R&D expenses, which contributed to the profit decline despite revenue growth [1]